chlorzoxazone has been researched along with Diffuse Myofascial Pain Syndrome in 2 studies
Chlorzoxazone: A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)
chlorzoxazone : A member of the class of 1,3-benzoxazoles that is 1,3-benzoxazol-2-ol in which the hydrogen atom at position 5 is substituted by chlorine. A centrally acting muscle relaxant with sedative properties, it is used for the symptomatic treatment of painful muscle spasm.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CATALAN PELLET, A | 1 |
| PEAK, WP | 1 |
| SMITH, RT | 1 |
2 other studies available for chlorzoxazone and Diffuse Myofascial Pain Syndrome
| Article | Year |
|---|---|
[Chlorzoxazone in musculo-articular disease].
Topics: Arthritis; Arthritis, Rheumatoid; Chlorzoxazone; Fibromyalgia; Humans; Joint Diseases; Osteoarthriti | 1962 |
Clinical comparison of chlorzoxazone and zoxazolamine with special reference to use of muscle relaxants in rheumatic diseases.
Topics: Cardiovascular Agents; Chlorzoxazone; Fibromyalgia; Referral and Consultation; Rheumatic Diseases; Z | 1960 |